233 related articles for article (PubMed ID: 9950646)
1. Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin.
Iwanaga K; Ono S; Narioka K; Kakemi M; Morimoto K; Yamashita S; Namba Y; Oku N
J Pharm Sci; 1999 Feb; 88(2):248-52. PubMed ID: 9950646
[TBL] [Abstract][Full Text] [Related]
2. [Effects of the liposomes coated by chitosan and its derivatives on the gastrointestinal transit of insulin].
Wu ZH; Ping QN; Lei XM; Li JY; Cai P
Yao Xue Xue Bao; 2005 Jul; 40(7):618-22. PubMed ID: 16196267
[TBL] [Abstract][Full Text] [Related]
3. Properties of liposomes coated with hydrophobically modified chitosan in oral liposomal drug delivery.
Thongborisute J; Takeuchi H; Yamamoto H; Kawashima Y
Pharmazie; 2006 Feb; 61(2):106-11. PubMed ID: 16526556
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats.
Goto T; Morishita M; Kavimandan NJ; Takayama K; Peppas NA
J Pharm Sci; 2006 Feb; 95(2):462-9. PubMed ID: 16381013
[TBL] [Abstract][Full Text] [Related]
5. The effect of particle structure of chitosan-coated liposomes and type of chitosan on oral delivery of calcitonin.
Thongborisute J; Tsuruta A; Kawabata Y; Takeuchi H
J Drug Target; 2006 Apr; 14(3):147-54. PubMed ID: 16753828
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
Takeuchi H; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
Int J Pharm; 2005 Oct; 303(1-2):160-70. PubMed ID: 16125348
[TBL] [Abstract][Full Text] [Related]
7. Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media.
Hu S; Niu M; Hu F; Lu Y; Qi J; Yin Z; Wu W
Int J Pharm; 2013 Jan; 441(1-2):693-700. PubMed ID: 23089580
[TBL] [Abstract][Full Text] [Related]
8. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models.
Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB
Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239
[TBL] [Abstract][Full Text] [Related]
9. In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration.
Inchaurraga L; Martín-Arbella N; Zabaleta V; Quincoces G; Peñuelas I; Irache JM
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):280-9. PubMed ID: 25541441
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.
Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y
Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840
[TBL] [Abstract][Full Text] [Related]
11. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes.
Takeuchi H; Yamamoto H; Niwa T; Hino T; Kawashima Y
Pharm Res; 1996 Jun; 13(6):896-901. PubMed ID: 8792429
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of PEG-coated silica nanoparticles for oral insulin delivery.
Andreani T; de Souza AL; Kiill CP; Lorenzón EN; Fangueiro JF; Calpena AC; Chaud MV; Garcia ML; Gremião MP; Silva AM; Souto EB
Int J Pharm; 2014 Oct; 473(1-2):627-35. PubMed ID: 25089510
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of liposomal behavior in the gastrointestinal tract after oral administration using real-time in vivo imaging.
Tahara K; Nishio M; Takeuchi H
Drug Dev Ind Pharm; 2018 Apr; 44(4):608-614. PubMed ID: 29166794
[TBL] [Abstract][Full Text] [Related]
14. Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form.
Anderson KE; Eliot LA; Stevenson BR; Rogers JA
Pharm Res; 2001 Mar; 18(3):316-22. PubMed ID: 11442271
[TBL] [Abstract][Full Text] [Related]
15. Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery.
Abu Lila AS; Uehara Y; Ishida T; Kiwada H
J Pharm Sci; 2014 Feb; 103(2):557-66. PubMed ID: 24347396
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics of insulin in polyethylene glycol-coated liposomes.
Kim A; Yun MO; Oh YK; Ahn WS; Kim CK
Int J Pharm; 1999 Mar; 180(1):75-81. PubMed ID: 10089294
[TBL] [Abstract][Full Text] [Related]
17. PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy.
Niu Z; Samaridou E; Jaumain E; Coëne J; Ullio G; Shrestha N; Garcia J; Durán-Lobato M; Tovar S; Santander-Ortega MJ; Lozano MV; Arroyo-Jimenez MM; Ramos-Membrive R; Peñuelas I; Mabondzo A; Préat V; Teixidó M; Giralt E; Alonso MJ
J Control Release; 2018 Apr; 276():125-139. PubMed ID: 29518466
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration.
Wang G; Kucharski C; Lin X; Uludağ H
J Drug Target; 2010 Sep; 18(8):611-26. PubMed ID: 20158316
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of submicronized chitosan-coated liposomes in oral absorption of indomethacin.
Sugihara H; Yamamoto H; Kawashima Y; Takeuchi H
J Liposome Res; 2012 Mar; 22(1):72-9. PubMed ID: 22329417
[TBL] [Abstract][Full Text] [Related]
20. Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract.
Masaoka Y; Tanaka Y; Kataoka M; Sakuma S; Yamashita S
Eur J Pharm Sci; 2006 Nov; 29(3-4):240-50. PubMed ID: 16876987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
